Microbot Medical Inc. (MBOT) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
25 RECREATION PARK DR SUITE 108 HINGHAM, MA 02043 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 5,470,000 | 6,385,000 | 8,202,000 | 15,492,000 | 24,648,000 | 31,292,000 | |||
| Cash and cash equivalent | 3,114,000 | 2,468,000 | 2,442,000 | 13,493,000 | 19,650,000 | 28,771,000 | |||
| Short-term investments | 2,356,000 | 3,917,000 | 5,760,000 | 1,999,000 | 4,998,000 | 2,521,000 | |||
| Restricted cash and investments | 49,000 | 49,000 | 77,000 | 87,000 | 84,000 | 4,358,000 | |||
| Inventory, net of allowances, customer advances and progress billings | |||||||||
| Inventory | |||||||||
| Prepaid expense | 211,000 | 91,000 | 429,000 | ||||||
| Deposits current assets | 3,000 | ||||||||
| Other current assets | 1,335,000 | 300,000 | 521,000 | 286,000 | |||||
| Other undisclosed current assets | 89,000 | 61,000 | 103,000 | ||||||
| Total current assets: | 5,819,000 | 7,921,000 | 8,814,000 | 15,879,000 | 25,253,000 | 35,936,000 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 132,000 | 260,000 | 502,000 | 644,000 | 775,000 | 962,000 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 80,000 | 146,000 | 221,000 | 244,000 | 251,000 | 228,000 | |||
| Restricted cash and investments | |||||||||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 212,000 | 406,000 | 723,000 | 888,000 | 1,026,000 | 1,190,000 | |||
| TOTAL ASSETS: | 6,031,000 | 8,327,000 | 9,537,000 | 16,767,000 | 26,279,000 | 37,126,000 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,390,000 | 1,384,000 | 1,786,000 | 1,706,000 | 1,158,000 | 1,079,000 | |||
| Accounts payable | 165,000 | 357,000 | 116,000 | 279,000 | 275,000 | 284,000 | |||
| Accrued liabilities | 2,225,000 | 1,027,000 | 1,670,000 | 1,427,000 | 883,000 | 795,000 | |||
| Debt | 143,000 | ||||||||
| Estimated litigation liability | 2,211,000 | ||||||||
| Other undisclosed current liabilities | 70,000 | 191,000 | 283,000 | 278,000 | 187,000 | 3,604,000 | |||
| Total current liabilities: | 2,460,000 | 3,786,000 | 2,069,000 | 1,984,000 | 1,345,000 | 4,826,000 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 402,000 | 626,000 | 760,000 | ||||||
| Liabilities, other than long-term debt | 41,000 | 40,000 | 179,000 | ||||||
| Operating lease, liability | 41,000 | 40,000 | 179,000 | 402,000 | 626,000 | 760,000 | |||
| Other undisclosed noncurrent liabilities | (402,000) | (626,000) | |||||||
| Total noncurrent liabilities: | 41,000 | 40,000 | 179,000 | 402,000 | 626,000 | 760,000 | |||
| Total liabilities: | 2,501,000 | 3,826,000 | 2,248,000 | 2,386,000 | 1,971,000 | 5,586,000 | |||
| Equity | |||||||||
| Equity, attributable to parent | 3,530,000 | 4,501,000 | 7,289,000 | 14,381,000 | 24,308,000 | 31,540,000 | |||
| Common stock | 195,000 | 118,000 | 80,000 | 72,000 | 72,000 | 72,000 | |||
| Treasury stock, value | (3,375,000) | ||||||||
| Additional paid in capital | 94,279,000 | 83,884,000 | 75,970,000 | 69,902,000 | 68,516,000 | 69,954,000 | |||
| Accumulated deficit | (90,944,000) | (79,501,000) | (68,761,000) | (55,593,000) | (44,280,000) | (35,111,000) | |||
| Total equity: | 3,530,000 | 4,501,000 | 7,289,000 | 14,381,000 | 24,308,000 | 31,540,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 6,031,000 | 8,327,000 | 9,537,000 | 16,767,000 | 26,279,000 | 37,126,000 | |||
Income Statement (P&L) (USD)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (11,625,000) | (9,855,000) | (13,281,000) | (11,357,000) | (9,089,000) | (7,240,000) | ||
| Operating loss: | (11,625,000) | (9,855,000) | (13,281,000) | (11,357,000) | (9,089,000) | (7,240,000) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (5,000) | |||||||
| Loss from continuing operations: | (11,625,000) | (9,855,000) | (13,286,000) | (11,357,000) | (9,089,000) | (7,240,000) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (11,357,000) | (9,089,000) | (7,240,000) | |
| Other undisclosed net income | 14,487,000 | |||||||
| Net income (loss): | (11,625,000) | (9,855,000) | (13,286,000) | (11,357,000) | (9,089,000) | 7,247,000 | ||
| Other undisclosed net income (loss) attributable to parent | 182,000 | (885,000) | 118,000 | 44,000 | (80,000) | (14,494,000) | ||
| Net loss attributable to parent: | (11,443,000) | (10,740,000) | (13,168,000) | (11,313,000) | (9,169,000) | (7,247,000) | ||
| Other undisclosed net income available to common stockholders, basic | 14,494,000 | |||||||
| Net income (loss) available to common stockholders, diluted: | (11,443,000) | (10,740,000) | (13,168,000) | (11,313,000) | (9,169,000) | 7,247,000 | ||
Comprehensive Income (USD)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (11,625,000) | (9,855,000) | (13,286,000) | (11,357,000) | (9,089,000) | 7,247,000 | ||
| Comprehensive income (loss): | (11,625,000) | (9,855,000) | (13,286,000) | (11,357,000) | (9,089,000) | 7,247,000 | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (80,000) | (14,494,000) | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (11,625,000) | (9,855,000) | (13,286,000) | (11,357,000) | (9,169,000) | (7,247,000) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.